Thomas Schreck Net Worth

The estimated Net Worth of Thomas A Schreck is at least $20.3 ezer dollars as of 29 August 2011. Mr. Schreck owns over 1,000 units of Ekso Bionics Inc stock worth over $20,345 and over the last 21 years he sold EKSO stock worth over $0. In addition, he makes $0 as Independent Director at Ekso Bionics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Schreck EKSO stock SEC Form 4 insiders trading

Thomas has made over 2 trades of the Ekso Bionics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of EKSO stock worth $3,270 on 29 August 2011.

The largest trade he's ever made was buying 2,000 units of Ekso Bionics Inc stock on 24 August 2011 worth over $6,020. On average, Thomas trades about 300 units every 1 days since 2004. As of 29 August 2011 he still owns at least 17,982 units of Ekso Bionics Inc stock.

You can see the complete history of Mr. Schreck stock trades at the bottom of the page.

Thomas Schreck biography

Thomas A. Schreck serves as Independent Director of the Company. Mr. Schreck has served as a member of our Board of Directors since October 30, 2018. Since June 2010, Mr. Schreck has served as the co-founder, Vice Chairman and Chief Executive Officer of Sinusys Corp., a medical device company. From July 2005 to June 2010, Mr. Schreck served as the co-founder, Chairman of the Board and Chief Executive Officer of AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company listed on the Nasdaq Stock Market. Prior to July 2005, Mr. Schreck served as a founding President, and then Chief Financial Officer and a director of DURECT Corporation, a specialty pharmaceutical company he co-founded in June 1998. Prior to 1998, Mr. Schreck held various investment banking positions in the San Francisco Bay Area and London, including with Montgomery Securities and Manufacturers Hanover Limited. Mr. Schreck holds a B.A. in American Studies from Williams College.

How old is Thomas Schreck?

Thomas Schreck is 62, he's been the Independent Director of Ekso Bionics Inc since 2018. There are 3 older and 7 younger executives at Ekso Bionics Inc. The oldest executive at Ekso Bionics Holdings Inc is Steven A. Sherman, 75, who is the Exec. Chairman.

What's Thomas Schreck's mailing address?

Thomas's mailing address filed with the SEC is C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND, CA, 94804.

Insiders trading at Ekso Bionics Inc

Over the last 9 years, insiders at Ekso Bionics Inc have traded over $898,173 worth of Ekso Bionics Inc stock and bought 276,997 units worth $399,153 . The most active insiders traders include Theodore T Wang, Steven Sherman és Russ Angold. On average, Ekso Bionics Inc executives and independent directors trade stock every 56 days with the average trade being worth of $25,243. The most recent stock trade was executed by Scott G. Davis on 17 August 2023, trading 37,446 units of EKSO stock currently worth $37,446.

What does Ekso Bionics Inc do?

since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774

Complete history of Mr. Schreck stock trades at Acelrx Pharmaceuticals Inc, Durect Corp és Ekso Bionics Inc

Ekso Bionics Inc executives and stock owners

Ekso Bionics Inc executives and other stock owners filed with the SEC include:

• Jack Peurach,
  President, Chief Executive Officer, Director
• William R. Shaw,
  Chief Commercial Officer
• John Glenn,
  Chief Financial Officer
• Jack Peurach,
  Pres, CEO & Director
• John F. Glenn,
  CFO & Sec.
• Jason Jones,
  Vice-President of Product Development
• Steven A. Sherman,
  Exec. Chairman
• Steven Sherman,
  Executive Chairman of the Board
• David Carey,
  IR Contact Officer
• William Shaw,
  Chief Commercial Officer
• Stanley Stern,
  Independent Director
• Marilyn Hamilton,
  Independent Director
• Theodore Wang,
  Director
• Thomas Schreck,
  Independent Director
• Charles Li,
  Independent Director
• Jerome Wong,
  Corp. Controller
• Foon Lim Chwee,
  Pres of APAC
• Anthony Pratt,
  US Director of Sales
• Rachael Anderson,
  Global Director of Marketing & Strategic Growth
• Scott G. Davis,
  President & COO
• Theodore T Puissance Cross ...,
  
• Russ Angold,
  President, Ekso Labs
• Tom Looby,
  President & Chief Com. Officer
• Kecheng Li,
  Director
• Russ De Lonzor,
  Vice Pres., Operations
• Max Scheder Bieschin,
  Chief Financial Officer
• Gregory Davault,
  Vice Pres., Global Marketing
• Daniel Boren,
  Director
• Amy Mc Bride Wendell,
  Director
• Howard D Palefsky,
  Director
• Nathan Harding,
  Chief Executive Officer
• Rhonda A. Wallen,
  Director
• Mary Ann Cloyd,
  Director
• Corinna Lathan,
  Director
• Deborah Lafer Scher,
  Director
• Jerome Wong,
  Chief Financial Officer